ACUPHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 10072956
Kong Haralds Vej 4, 4000 Roskilde
jeanne@acupharma.dk
tel: 70228848
www.acupharma.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 684.29 | 1 367.55 | 1 184.85 | 778.37 | 1 128.20 |
| Employee benefit expenses | -1 315.78 | -1 354.43 | - 907.70 | - 921.36 | - 723.94 |
| Other operating expenses | -63.29 | ||||
| Total depreciation | - 185.85 | - 184.91 | - 174.48 | - 111.41 | - 104.52 |
| EBIT | 182.66 | - 171.78 | 102.67 | - 317.70 | 299.73 |
| Other financial income | 0.03 | 0.49 | |||
| Other financial expenses | - 138.96 | - 127.52 | -94.22 | - 102.36 | - 146.97 |
| Pre-tax profit | 43.72 | - 299.30 | 8.45 | - 420.06 | 153.25 |
| Income taxes | -10.88 | 64.73 | -2.40 | -29.57 | |
| Net earnings | 32.84 | - 234.58 | 6.05 | - 449.63 | 153.25 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 360.67 | 261.48 | 167.28 | 162.19 | 89.07 |
| Intangible assets total | 360.67 | 261.48 | 167.28 | 162.19 | 89.07 |
| Buildings | 135.61 | 93.18 | 63.29 | 107.14 | 90.07 |
| Machinery and equipment | 98.07 | 54.78 | 27.03 | 33.53 | 15.23 |
| Tangible assets total | 233.68 | 147.97 | 90.32 | 140.67 | 105.30 |
| Other receivables | 70.04 | 70.04 | 70.04 | ||
| Investments total | 70.04 | 70.04 | 70.04 | ||
| Long term receivables total | |||||
| Finished products/goods | 1 138.83 | 844.99 | 778.40 | 574.12 | 413.81 |
| Inventories total | 1 138.83 | 844.99 | 778.40 | 574.12 | 413.81 |
| Current trade debtors | 680.50 | 584.44 | 628.17 | 617.26 | 730.07 |
| Current amounts owed by group member comp. | 395.25 | 404.05 | 420.36 | 437.51 | 454.89 |
| Prepayments and accrued income | 334.77 | 163.35 | 167.27 | 63.86 | 88.80 |
| Current other receivables | 48.95 | 36.90 | 43.74 | 13.63 | 219.91 |
| Current deferred tax assets | 31.97 | 29.57 | |||
| Short term receivables total | 1 459.47 | 1 220.71 | 1 289.12 | 1 132.26 | 1 493.67 |
| Cash and bank deposits | 29.54 | 5.09 | 2.12 | 1.65 | 1.65 |
| Cash and cash equivalents | 29.54 | 5.09 | 2.12 | 1.65 | 1.65 |
| Balance sheet total (assets) | 3 292.25 | 2 550.29 | 2 397.29 | 2 010.88 | 2 103.50 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 |
| Retained earnings | 53.97 | 86.81 | - 147.77 | - 141.72 | - 591.35 |
| Profit of the financial year | 32.84 | - 234.58 | 6.05 | - 449.63 | 153.25 |
| Shareholders equity total | 386.81 | 152.23 | 158.28 | - 291.35 | - 138.11 |
| Provisions | 32.75 | ||||
| Non-current loans from credit institutions | 75.91 | ||||
| Non-current deferred tax liabilities | 7.15 | 24.19 | 24.19 | 24.98 | 25.85 |
| Non-current liabilities total | 83.06 | 24.19 | 24.19 | 24.98 | 25.85 |
| Current loans from credit institutions | 1 188.66 | 1 321.40 | 1 046.82 | 996.90 | 1 044.25 |
| Current trade creditors | 992.48 | 509.67 | 257.46 | 466.31 | 482.93 |
| Other non-interest bearing current liabilities | 608.50 | 542.79 | 910.55 | 714.05 | 608.57 |
| Accruals and deferred income | 100.00 | 80.00 | |||
| Current liabilities total | 2 789.63 | 2 373.86 | 2 214.82 | 2 277.26 | 2 215.75 |
| Balance sheet total (liabilities) | 3 292.25 | 2 550.29 | 2 397.29 | 2 010.88 | 2 103.50 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.